Host-microbiota interactions in inflammatory bowel disease

Gut Microbes

Volumn 3, Issue 4, 2012, Pages

  Elson, Charles O ^a   Cong, Yingzi ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adaptive immunity; B cell; Dendritic cell; Dysbiosis; Epithelial cell; Innate immunity; Macrophage; Microbiota; Mucin; T cell; T regulatory cell; Th1; Th17

Indexed keywords

MUCIN;

ADAPTIVE IMMUNITY; BACTEROIDES; CD4+ T LYMPHOCYTE; CLOSTRIDIA; CROHN DISEASE; DENDRITIC CELL; EFFECTOR CELL; ENTERITIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FIRMICUTES; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; KLEBSIELLA; LACHNOSPIRACEAE; LYMPHOID CELL; MACROPHAGE; NONHUMAN; PROTEOBACTERIA; PROTEUS; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; BACTERIUM; DISEASE MODEL; GASTROINTESTINAL TRACT; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY;

MUS;

ANIMALS; BACTERIA; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE;

EID: 84863872794     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.20228     Document Type: Review

References (133)

1. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206:260-76; PMID:16048554; http://dx.doi.org/10.1111/j.0105-2896.2005.00291.x.
2. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 2011; 11:9-20; PMID:21151034; http:// dx.doi.org/10.1038/nri2891.
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474:307-17; PMID:21677747; http://dx.doi. org/10.1038/nature10209.
4. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449:804-10; PMID:17943116; http://dx.doi.org/10.1038/nature06244.
5. Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, et al.; Human Microbiome Jumpstart Reference Strains Consortium. A catalog of reference genomes from the human microbiome. Science 2010; 328:994-9; PMID:20489017; http://dx.doi.org/10.1126/science.1183605.
6. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694-7; PMID:19892944; http://dx.doi. org/10.1126/science.1177486.
7. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-4; PMID:19043404; http://dx.doi.org/10.1038/ nature07540.
8. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/ nature08821.
9. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al.; MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 2011; 473:174-80; PMID:21508958; http://dx.doi. org/10.1038/nature09944.
10. Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med 2011; 3:14; PMID:21392406; http://dx.doi. org/10.1186/gm228.
11. +T cells and commensal microbiota. J Immunol 2008; 180:5843-52; PMID:18424703.
12. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16:228-31; PMID:20081863; http://dx.doi.org/10.1038/nm.2087.
13. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011; 108:5354-9; PMID:21402903; http://dx.doi.org/10.1073/ pnas.1019378108.
14. Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104:13780-5; PMID:17699621; http://dx.doi. org/10.1073/pnas.0706625104.
15. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105:16731-6; PMID:18936492; http:// dx.doi.org/10.1073/pnas.0804812105.
16. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007; 5:2177-89; PMID:17760501; http://dx.doi.org/10.1371/journal. pbio.0050244.
17. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:119-29; PMID:18005726; http://dx.doi.org/10.1016/j.chom.2007.06.010.
18. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-21; PMID:15300573; http://dx.doi.org/10.1053/j. gastro.2004.04.061.
19. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12:99-113; PMID:19747213; http:// dx.doi.org/10.1111/j.1462-5822.2009.01381.x.
20. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33-45; PMID:17923086; http://dx.doi.org/10.1016/j.cell.2007.08.017.
21. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8:292-300; PMID:20833380; http://dx.doi. org/10.1016/j.chom.2010.08.004.
22. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011; 9:390-403; PMID:21575910; http:// dx.doi.org/10.1016/j.chom.2011.04.009.
23. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005; 128:891-906; PMID:15825073; http://dx.doi. org/10.1053/j.gastro.2005.02.009.
24. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113:1296-306; PMID:15124021.
25. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-84; PMID:20839241; http:// dx.doi.org/10.1002/ibd.21339.
26. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodiuminduced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52; PMID:7958674.
27. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464:1371-5; PMID:20393462; http:// dx.doi.org/10.1038/nature08949.
28. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306; PMID:21677746; http://dx.doi. org/10.1038/nature10208.
29. Bergstrom KSB, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 2010; 6:1000902; PMID:20485566; http:// dx.doi.org/10.1371/journal.ppat.1000902.
30. Johansson MEV, Larsson JMH, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 2011; 108:4659-65; PMID:20615996; http://dx.doi. org/10.1073/pnas.1006451107.
31. Van der Sluis M, De Koning BAE, De Bruijn ACJM, Velcich A, Meijerink JPP, Van Goudoever JB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131:117-29; PMID:16831596; http://dx.doi.org/10.1053/j.gastro. 2006.04.020.
32. Larsson JMH, Karlsson H, Crespo JG, Johansson MEV, Eklund L, Sjövall H, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis 2011; 17:2299-307; PMID:21290483; http://dx.doi.org/10.1002/ibd.21625.
33. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008; 134:743-56; PMID:18775308; http://dx.doi.org/10.1016/j. cell.2008.07.021.
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41; PMID:15260992; http://dx.doi.org/10.1016/j. cell.2004.07.002.
35. Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009; 58:1481-9; PMID:19570762; http:// dx.doi.org/10.1136/gut.2008.175166.
36. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446:557-61; PMID:17361131; http://dx.doi. org/10.1038/nature05698.
37. Vereecke L, Sze M, Mc Guire C, Rogiers B, Chu Y, Schmidt-Supprian M, et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factorinduced toxicity and experimental colitis. J Exp Med 2010; 207:1513-23; PMID:20530205; http://dx.doi. org/10.1084/jem.20092474.
38. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, Lee B, et al. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med 2008; 205:451-64; PMID:18268035; http://dx.doi.org/10.1084/ jem.20071108.
39. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998; 161:5733-44; PMID:9820555.
40. Lencioni KC, Seamons A, Treuting PM, Maggio-Price L, Brabb T. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp Med 2008; 58:522-33; PMID:19149409.
41. Huett A, Xavier RJ. Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16:152-74; PMID:19575363.
42. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456:259-63; PMID:18849966; http://dx.doi.org/10.1038/ nature07416.
43. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng ACY, Storer CE, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141:1135-45; PMID:20602997; http://dx.doi.org/10.1016/j. cell.2010.05.009.
44. Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:1284-92; PMID:17567878; http://dx.doi.org/10.1002/ ibd.20197.
45. Travassos LH, Carneiro LAM, Ramjeet M, Hussey S, Kim YG, Magalhães JG, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11:55-62; PMID:19898471; http://dx.doi. org/10.1038/ni.1823.
46. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264-8; PMID:18849965; http:// dx.doi.org/10.1038/nature07383.
47. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010; 32:379-91; PMID:20303296; http://dx.doi.org/10.1016/j. immuni.2010.03.003.
48. Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KSB, McIntire CR, LeBlanc PM, et al. Control of intestinal homeostasis, colitis and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010; 32:367-78; PMID:20226691; http:// dx.doi.org/10.1016/j.immuni.2010.02.012.
49. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34:665-79; PMID:21616436; http://dx.doi.org/10.1016/j.immuni.2011.05.007.
50. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011; 34:122-34; PMID:21194981; http://dx.doi. org/10.1016/j.immuni.2010.12.009.
51. Qiu J, Heller JJ, Guo X, Chen ZM, Fish K, Fu YX, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012; 36:92-104; PMID:22177117; http:// dx.doi.org/10.1016/j.immuni.2011.11.011.
52. Tumanov AV, Koroleva EP, Guo X, Wang Y, Kruglov A, Nedospasov S, et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 2011; 10:44-53; PMID:21767811; http:// dx.doi.org/10.1016/j.chom.2011.06.002.
53. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JKM, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-5; PMID:18978771; http://dx.doi.org/10.1038/nature07537.
54. Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, et al. Imbalance of NKp44(+) NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010; 139:882-92; PMID:20638936; http://dx.doi.org/10.1053/j.gastro. 2010.05.040.
55. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31:331-41; PMID:19682929; http:// dx.doi.org/10.1016/j.immuni.2009.08.001.
56. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31:321-30; PMID:19682928; http://dx.doi.org/10.1016/j.immuni. 2009.06.020.
57. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115:66-75; PMID:15630445.
58. Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, et al. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NFkappaB inactivation. J Biol Chem 2010; 285:19593-604; PMID:20388715; http://dx.doi.org/10.1074/jbc.M109.069955.
59. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007; 8:1086-94; PMID:17873879; http://dx.doi. org/10.1038/ni1511.
60. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012; 209:139-55; PMID:22231304; http:// dx.doi.org/10.1084/jem.20101387.
61. Kim YG, Kamada N, Shaw MH, Warner N, Chen GY, Franchi L, et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 2011; 34:769-80; PMID:21565531; http:// dx.doi.org/10.1016/j.immuni.2011.04.013.
62. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206:1883-97; PMID:19652016; http://dx.doi. org/10.1084/jem.20091233.
63. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10:39-49; PMID:10023769; http://dx.doi.org/10.1016/ S1074-7613(00)80005-9.
64. Welte T, Zhang SSM, Wang T, Zhang Z, Hesslein DGT, Yin Z, et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci USA 2003; 100:1879-84; PMID:12571365; http://dx.doi.org/10.1073/pnas.0237137100.
65. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15:103-13; PMID:19185845; http://dx.doi.org/10.1016/j. ccr.2009.01.001.
66. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009; 206:1465-72; PMID:19564350; http://dx.doi.org/10.1084/jem.20082683.
67. Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010; 32:605-15; PMID:20493732; http://dx.doi.org/10.1016/j.immuni. 2010.05.003.
68. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009; 119:2441-50; PMID:19729841; http://dx.doi.org/10.1172/ JCI39134.
69. +regulatory T cells via a TGFbeta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-64; PMID:17620361; http://dx.doi. org/10.1084/jem.20070590.
70. +dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008; 205:2139-49; PMID:18710932; http://dx.doi. org/10.1084/jem.20080414.
71. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010; 329:849-53; PMID:20705860; http://dx.doi.org/10.1126/science. 1188510.
72. Siddiqui KRR, Laffont S, Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 2010; 32:557-67; PMID:20399121; http://dx.doi.org/10.1016/j.immuni. 2010.03.017.
73. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-9; PMID:18264109; http://dx.doi.org/10.1038/nm1720.
74. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, et al. Monoclonal antiinterleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007; 132:2359-70; PMID:17570211; http://dx.doi.org/10.1053/j. gastro.2007.03.104.
75. Kan SH, Mancini G, Gallagher G. Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun 2008; 9:631-9; PMID:18754016; http://dx.doi.org/10.1038/ gene.2008.64.
76. Hedl M, Li J, Cho JH, Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA 2007; 104:19440-5; PMID:18032608; http://dx.doi.org/10.1073/ pnas.0706097104.
77. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16:90-7; PMID:19966812; http://dx.doi.org/10.1038/ nm.2069.
78. Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 2010; 139:1630-41; PMID:20637199; http://dx.doi. org/10.1053/j.gastro.2010.07.006.
79. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298:1424-7; PMID:12434060; http:// dx.doi.org/10.1126/science.1077336.
80. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41; PMID:21205640; http://dx.doi. org/10.1126/science.1198469.
81. Geuking MB, Cahenzli J, Lawson MAE, Ng DCK, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34:794-806; PMID:21596591; http://dx.doi.org/10.1016/j.immuni.2011.03.021.
82. +T helper cells. Cell 2006; 126:1121-33; PMID:16990136; http://dx.doi. org/10.1016/j.cell.2006.07.035.
83. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5; PMID:18509436; http://dx.doi.org/10.1038/nature07008.
84. +regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107:12204-9; PMID:20566854; http://dx.doi. org/10.1073/pnas.0909122107.
85. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-27; PMID:20620945; http://dx.doi.org/10.1016/j.immuni.2010.06.001.
86. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34:794-806; PMID:21596591; http://dx.doi.org/10.1016/j.immuni.2011.03.021.
87. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108:4615-22; PMID:20660719; http://dx.doi.org/10.1073/ pnas.1000082107.
88. +T cells. Inflamm Bowel Dis 2007; 13:1202-11; PMID:17607724; http://dx.doi. org/10.1002/ibd.20221.
89. Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996; 98:1010-20; PMID:8770874; http:// dx.doi.org/10.1172/JCI118861.
90. +lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFNgamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70; PMID:8757634.
91. +T cells. Immunity 1994; 1:553-62; PMID:7600284; http://dx.doi.org/10.1016/1074-7613(94)90045-0.
92. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-6; PMID:16670770; http://dx.doi.org/10.1172/JCI21404.
93. Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F, et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are downregulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 2006; 12:9-15; PMID:16374252; http://dx.doi.org/10.1097/01. MIB.0000194183.92671.b6.
94. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008; 57:1682-9; PMID:18653729; http://dx.doi.org/10.1136/gut.2007.135053.
95. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112:1169-78; PMID:9098000; http://dx.doi. org/10.1016/S0016-5085(97)70128-8.
96. Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 2009; 137:1736-45; PMID:19632232; http://dx.doi.org/10.1053/j.gastro. 2009.07.049.
97. Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, et al. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 2005; 11:16-23; PMID:15674109; http://dx.doi.org/10.1097/00054725-200501000-00003.
98. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, et al. The transcription factor T-beta regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002; 195:1129-43; PMID:11994418; http://dx.doi. org/10.1084/jem.20011956.
99. +T cells that respond to bacterial antigens. J Immunol 1999; 162:1884-8; PMID:9973454.
100. Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, Fisher SA, et al.; Wellcome Trust Case Control Consortium. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009; 136:523-9; PMID:19068216; http://dx.doi.org/10.1053/j.gastro. 2008.10.032.
101. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8:458-66; PMID:18500230; http://dx.doi. org/10.1038/nri2340.
102. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461-3; PMID:17068223; http://dx.doi.org/10.1126/science.1135245.
103. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, et al.; Anti-IL-12 Crohn's Disease Study Group. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 2004; 351:2069-79; PMID:15537905; http://dx.doi.org/10.1056/ NEJMoa033402.
104. Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, et al.; Ustekinumab Crohn's Disease Study Group. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008; 135:1130-41; PMID:18706417; http://dx.doi.org/10.1053/j.gastro. 2008.07.014.
105. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFNgamma axis. J Clin Invest 2008; 118:2269-80; PMID:18497880.
106. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8:639-46; PMID:17486092; http://dx.doi. org/10.1038/ni1467.
107. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849-61; PMID:17635957; http://dx.doi. org/10.1084/jem.20070663.
108. Feng T, Qin H, Wang L, Benveniste EN, Elson CO, Cong Y. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol 2011; 186:6313-8; PMID:21531892; http://dx.doi.org/10.4049/jimmunol. 1001454.
109. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478:250-4; PMID:21937990; http:// dx.doi.org/10.1038/nature10434.
110. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-1; PMID:11137993; http:// dx.doi.org/10.1038/83713.
111. +T cells during cure of colitis. J Immunol 2006; 177:5852-60; PMID:17056509.
112. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 2007; 26:579-91; PMID:17481928; http:// dx.doi.org/10.1016/j.immuni.2007.03.014.
113. Roers A, Siewe L, Strittmatter E, Deckert M, Schlüter D, Stenzel W, et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 2004; 200:1289-97; PMID:15534372; http://dx.doi.org/10.1084/ jem.20041789.
114. +and Foxp3-precursor cells in the absence of interleukin Nat Immunol 2007; 8:931-41; PMID:17694059; http://dx.doi.org/10.1038/ni1504.
115. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al.; IBSEN study group. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008; 40:1319-23; PMID:18836448; http:// dx.doi.org/10.1038/ng.221.
116. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361:2033-45; PMID:19890111; http:// dx.doi.org/10.1056/NEJMoa0907206.
117. +regulatory T cells, Th17 effector cells and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010; 30:80-9; PMID:19936899; http://dx.doi.org/10.1007/s10875-009-9345-1.
118. +CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006; 12:447-56; PMID:16775488; http://dx.doi. org/10.1097/00054725-200606000-00003.
119. Li Z, Arijs I, De Hertogh G, Vermeire S, Noman M, Bullens D, et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis 2010; 16:1299-310; PMID:20196149.
120. +CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128:1868-78; PMID:15940622; http://dx.doi.org/10.1053/j.gastro. 2005.03.043.
121. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011; 17:1585-93; PMID:22101768; http://dx.doi. org/10.1038/nm.2505.
122. Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007; 2:328-39; PMID:18005754; http://dx.doi.org/10.1016/j. chom.2007.09.013.
123. Wei M, Shinkura R, Doi Y, Maruya M, Fagarasan S, Honjo T. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat Immunol 2011; 12:264-70; PMID:21258321; http://dx.doi.org/10.1038/ni.1991.
124. Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci USA 2009; 106:19256-61; PMID:19889972; http://dx.doi. org/10.1073/pnas.0812681106.
125. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303:1662-5; PMID:15016999; http:// dx.doi.org/10.1126/science.1091334.
126. Cazac BB, Roes J. TGFbeta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000; 13:443-51; PMID:11070163; http://dx.doi. org/10.1016/S1074-7613(00)00044-3.
127. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 1997; 186:1749-56; PMID:9362534; http://dx.doi. org/10.1084/jem.186.10.1749.
128. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 2011; 178:735-43; PMID:21281806; http://dx.doi. org/10.1016/j.ajpath.2010.10.022.
129. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16:219-30; PMID:11869683; http://dx.doi. org/10.1016/S1074-7613(02)00274-1.
130. Feng T, Elson CO, Cong Y. Microbiota: dual-faceted player in experimental colitis. Gut Microbes 2010; 1:388-91; PMID:21468221; http://dx.doi. org/10.4161/gmic.1.6.13727.
131. Beckwith J, Cong Y, Sundberg JP, Elson CO, Leiter EH. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 2005; 129:1473-84; PMID:16285949; http://dx.doi.org/10.1053/j. gastro.2005.07.057.
132. +innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12:320-6; PMID:21336274; http:// dx.doi.org/10.1038/ni.2002.
133. +immune cells in spleen and mucosa. J Immunol 2010; 185:1177-85; PMID:20566828; http://dx.doi.org/10.4049/jimmunol.1000115.